By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Novavax, Inc. 

9920 Belward Campus Drive

Rockville  Maryland  20850  U.S.A.
Phone: 240-268-2000 Fax: n/a


SEARCH JOBS


Industry
Biotechnology

Segment
Drug Delivery





Company News
U.S. FDA Grants Fast Track Designation To Novavax, Inc. (NVAX)' RSV F-Protein Nanoparticle Vaccine For Protection Of Infants Via Maternal Immunization 11/20/2014 7:24:38 AM
Novavax, Inc. (NVAX) Initiates Phase 2 Clinical Trial Of Quadrivalent Seasonal Influenza VLP 11/17/2014 2:33:59 PM
Novavax, Inc. (NVAX) To Present At The Jefferies and Co. Global Healthcare Conference 11/13/2014 10:47:30 AM
Novavax, Inc. (NVAX) Initiates Phase 1 Clinical Trial Of RSV F Vaccine In Pediatric Subjects 11/10/2014 7:21:03 AM
Novavax, Inc. (NVAX) And Collaborators Make Multiple Presentations At The 9th International Respiratory Syncytial Virus Symposium In South Africa, November 9 - 13, 2014 11/7/2014 10:26:50 AM
Novavax, Inc. (NVAX) Reports Third Quarter 2014 Financial Results 11/6/2014 8:44:50 AM
FDA Grants Fast Track Designation To Novavax, Inc. (NVAX)' H7N9 Influenza Virus-Like Particle Vaccine Candidate Adjuvanted With Matrix-M™ 10/30/2014 10:07:37 AM
Novavax, Inc. (NVAX) To Host Conference Call To Discuss Third Quarter 2014 Financial Results On November 5, 2014 10/30/2014 8:34:01 AM
Novavax, Inc. (NVAX) Announces Ebola Vaccine Development Program At The 8th Vaccine And ISV Conference In Philadelphia 10/27/2014 10:16:50 AM
Novavax, Inc. (NVAX) Presents RSV F Protein Nanoparticle Vaccine Clinical Data At The 8th Vaccine & ISV Congress In Philadelphia On Sunday, October 26 10/27/2014 10:10:00 AM
12345678910...
//-->